U.S. Electrical Stock News

If you are wondering whether Carlyle Group's current share price offers good value or not, the recent mix of returns and valuation checks makes it a stock worth looking at more closely. Carlyle Group closed at US$47.72, with returns of 4.5% over 30 days, a 21.6% decline year to date, a 25.2% gain over 1 year, and an 80.5% return over 3 years. Recent coverage has focused on how private markets managers like Carlyle Group are responding to shifting fundraising conditions and deal activity, as...

Event context and recent share performance TWFG (TWFG) has drawn fresh attention after recent price moves, as the stock trades around $19.90 with mixed short term returns. This includes a roughly 13.5% gain over the past month and a 21.6% decline over the past 3 months. See our latest analysis for TWFG. For TWFG, the recent 13.5% 1 month share price return comes after a weaker period, with the 3 month share price return down 21.6% and the 1 year total shareholder return down 37.0%. This...

Affirm Holdings (NasdaqGS:AFRM) has launched "The Big Nothing" event, offering thousands of 0% APR installment options to eligible shoppers. The promotion focuses on interest free, flexible payment plans across a wide range of purchases. The campaign is designed as a large scale, consumer facing push for Affirm's buy now, pay later services. Affirm operates in the buy now, pay later space, giving shoppers installment options at the point of sale. "The Big Nothing" puts that model in front...

Earlier this month, Foundation Medicine announced an expanded collaboration with Bristol-Myers Squibb to develop FoundationOne CDx as a next-generation sequencing-based companion diagnostic to identify patients with homozygous MTAP deletion for an investigational targeted cancer therapy. This move underlines Bristol-Myers Squibb’s push deeper into precision oncology, where better patient selection tools could enhance the impact and utilization of its future therapies. Next, we’ll examine how...

AEVEX stock reaction and recent price performance AEVEX (AVEX) shares closed at $29.90, with the stock showing an 11.9% decline over the past day and a 16.9% decline over the past week, while year-to-date performance remains positive. See our latest analysis for AEVEX. The sharp 1 day share price return of negative 11.9% and 7 day share price return of negative 16.9% sit against a year to date share price return of 11%, suggesting that recent momentum has cooled after earlier gains. If you...

Levi Strauss (NYSE:LEVI) has appointed Troy Alstead as its next board chair, succeeding Robert Eckert as he steps down. Director Chris McCormick is retiring from the board as part of the latest governance changes. The company reported Q1 growth with rising direct to consumer revenue now accounting for more than 50% of sales, alongside global brand initiatives. For investors tracking NYSE:LEVI, these leadership shifts arrive alongside a share price of $22.3 and a 45.1% gain over the past...

If you are wondering whether IQVIA Holdings is priced fairly or if the recent share price is offering you an opening, this article focuses squarely on what the current valuation is indicating. The stock last closed at US$158.98, with returns of 3.6% over 1 year, but year to date the share price is down 29.5%. This includes a 9.5% fall over the past week and a 3% decline over the past month. These moves sit against a longer backdrop where the stock shows a 14.3% decline over 3 years and a...

If you are wondering whether Intuitive Machines at around US$24.58 is still offering value after a big run, you are not alone. This article focuses squarely on what that price may or may not reflect. The stock has been volatile, with an 11.6% decline over the last 7 days contrasted against gains of 40.3% over 30 days, 37.5% year to date and 185.8% over the past year. Recent news coverage has centred on Intuitive Machines' role in the growing commercial space sector and its exposure to high...

Investors may be wondering whether Cal-Maine Foods at around US$77 a share still offers value, or if most of the easy gains are already behind it. The stock has barely moved over the past week and month, with returns of 0.3% over 7 days and 0.2% over 30 days, while the 1 year return of a 12.9% decline contrasts with a 166.7% gain over 5 years. Recent headlines have focused on Cal-Maine Foods' role in the egg market and how pricing, supply trends, and consumer demand continue to frame the...

Butterfly Network (BFLY) recently appointed Arun Nagdev, MD as Chief Medical Officer for Point of Care Ultrasound, placing a seasoned clinician and ultrasound specialist at the center of its global medical and product validation strategy. See our latest analysis for Butterfly Network. The appointment of Dr. Nagdev comes as Butterfly Network’s 1 month share price return of 31.63% and 90 day share price return of 19.72% contrast with a 5 day pullback, while the 1 year total shareholder return...

Recent commentary on Natural Resource Partners L.P. highlights growing investor interest in its royalty-focused business model, ongoing debt reduction, and emphasis on returning cash to unitholders through distributions and buybacks. An interesting angle for investors is the prospect of the partnership approaching near net-zero debt while potentially layering in additional special distributions over time. With this backdrop, we will explore how Natural Resource Partners’ accelerated debt...

Uranium Energy Corp recently received approval from the Texas Commission on Environmental Quality to begin operations at its Burke Hollow in-situ recovery uranium project, the first new ISR uranium operation to launch in the United States in over a decade. This regulatory milestone strengthens Uranium Energy’s position in U.S.-sourced nuclear fuel and could influence how investors view its long-term production profile. We’ll now examine how Burke Hollow’s newly approved ISR operations could...

Alexandria Real Estate Equities (ARE) opened 2026 with Q1 funds from operations of US$636.9 million, basic EPS of US$2.10 and total revenue of US$670.9 million, setting a fresh reference point after a volatile stretch of results in 2025. Over recent quarters, revenue has moved from US$795.6 million in Q4 2024 to a range between US$752.1 million and US$757.7 million across 2025 before landing at US$670.9 million in Q1 2026, while basic EPS has swung from a loss of US$0.38 in Q4 2024 to a loss...

Hilton Worldwide Holdings (HLT) opened 2026 with Q1 revenue of US$2.9b and basic EPS of US$1.68, setting the tone for how its fee driven model is translating into bottom line results. Over the last five reported quarters, revenue has ranged from US$1.1b to US$2.9b while basic EPS moved between US$1.25 and US$2.08, giving investors a clear view of how earnings have tracked alongside a growing top line. With trailing net profit margins reported at 29.7%, down from 33% a year earlier, this...

Waystar Holding (WAY) has put its AI ambitions front and center, rolling out new AltitudeAI capabilities that target healthcare revenue cycle automation, silent denials, revenue leakage, and personalized patient billing, supported by an expanded Google Cloud collaboration. See our latest analysis for Waystar Holding. Despite the recent AltitudeAI launch and conference activity, Waystar Holding’s 1-month share price return of 7.54% comes alongside a year-to-date share price return of 19.57%...

If you are wondering whether Weibo's current share price still reflects its underlying value, the recent trading history gives you a lot to think about. The stock last closed at US$8.14, with returns of 6.9% over 1 year but declines of 5.7% over 7 days, 5.1% over 30 days, 22.8% year to date, 29.8% over 3 years and 76.7% over 5 years. Recent headlines around Weibo have focused on its role within social media and digital advertising, alongside ongoing attention on user engagement trends and...

ON Semiconductor (NasdaqGS:ON) is expanding collaborations with Chinese automakers NIO and Geely Auto Group. The partnerships focus on next generation 900V electric vehicle platforms using ON's EliteSiC technology. The news highlights closer integration between EV manufacturers and semiconductor suppliers in high voltage architectures. For investors tracking ON Semiconductor at a current share price of $93.3, this development adds a fresh angle to the story around its role in electric...

If you are wondering whether AdaptHealth's current share price still offers value, it helps to step back and look at what recent performance and fundamentals are really saying. The stock closed at US$13.38, with returns of 10.1% over the last week, 19.5% over the last month, 38.4% year to date, and 59.9% over the past year. This puts recent price action firmly on investors' radar. These moves have come as AdaptHealth continues to attract attention within the healthcare sector, with investors...

NRG Energy, through its Lightning Power subsidiary, has received over 99% early tenders in a cash offer for its 7.250% senior secured notes. The company also secured the required consents to amend the notes indenture, clearing the way to remove restrictive covenants and release certain guarantees and collateral. This debt move positions NRG to adjust its balance sheet structure and future obligations in a single, concentrated transaction. NRG Energy (NYSE:NRG), recently trading at about...

Wondering if Primoris Services at around US$168.94 is still reasonably priced after such a strong run, or if you might be late to the story. The stock shows returns of 2.6% over 7 days, 17.7% over 30 days, 29.3% year to date and 176.4% over 1 year, with a very large 3 year return and 428.8% over 5 years that naturally raise questions about current value and risk. Recent coverage around Primoris Services has focused on its share price strength over multiple timeframes and what that could mean...

What recent performance says about Globalstar (GSAT) With no single headline event in focus, Globalstar (GSAT) has still attracted attention after a roughly 31% return over the past month and about 26% over the past 3 months. See our latest analysis for Globalstar. Those short term share price gains sit on top of a very large 1 year total shareholder return, alongside multi year total shareholder returns that are also multiples of the initial investment. This signals strong momentum in how...

Immunocore Holdings plc recently reported five-year overall survival data for KIMMTRAK in unresectable or metastatic uveal melanoma, showing an OS rate of 16% versus 8% for investigator’s choice in the longest prospective Phase 3 randomized trial for this disease. These results also mark the longest follow-up yet reported for a T cell engager in a solid tumor, highlighting KIMMTRAK’s durable clinical impact in a setting with historically very poor long-term outcomes. We’ll now examine how...

Wondering if Globus Medical at around US$90.74 is priced for opportunity or already reflects the story? This article walks through the numbers so you can see how its current tag lines up with its fundamentals. The share price has moved by 3.9% year to date, with a 30 day return of 8.3% and a 1 year return of 25.5%, even after a recent 7 day decline of 3.3%. Recent coverage has focused on Globus Medical as a medical devices company in the healthcare sector and how its position in that space...

Coca-Cola (KO) opened 2026 with Q1 revenue of US$12.5b and basic EPS of US$0.91, setting the tone for another data rich earnings season for the drinks giant. The company has seen quarterly revenue move from US$11.1b and EPS of US$0.77 in Q1 2025 to US$12.5b and EPS of US$0.91 in Q1 2026, while trailing twelve month EPS reached US$3.18, giving investors a clear view of consistent earnings delivery. With trailing net margins at 27.8% and earnings growth of 26% over the past year, this update...